SSR181507

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2013
02420032013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Several novel antipsychotics activate serotonin 5-HT1A receptors as well as antagonising dopamine D2/3 receptors. Such a… (More)
Is this relevant?
2006
2006
Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade. We compared the… (More)
Is this relevant?
2006
2006
The effects of antipsychotics targeting dopamine D2 and serotonin 5-HT1A receptors were compared with conventional antipsychotics… (More)
Is this relevant?
2005
2005
Selective attention deficit, characterised by the inability to differentiate relevant from irrelevant information, is considered… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Serotonin 5-HT1A receptors are promising targets in the management of schizophrenia but little information exists about affinity… (More)
Is this relevant?
2005
2005
Several novel antipsychotics, such as aripiprazole, bifeprunox, SSR181507 [(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2005
2005
Considerable interest has arisen in identifying antipsychotic agents with improved efficacy against negative symptoms, such as… (More)
Is this relevant?
2005
2005
Compounds possessing 5-HT(1A) agonist properties attenuate catalepsy induced by D(2) receptor blockade. Here we examined the role… (More)
Is this relevant?
2004
2004
Social behaviour is frequently impaired in schizophrenic patients, and current antipsychotics appear poorly effective in… (More)
Is this relevant?
2003
2003
SSR181507 ((3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?